Luc Brans
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 8
- Monoclonal and Polyclonal Antibodies Research 3
- Oncology 7
- Peptidase Inhibition and Analysis 7
- Co-authors
- Dirk Tourwé (12 shared papers)Roger Schibli (9 shared papers)Véronique Maes (8 shared papers)Christian Schweinsberg (7 shared papers)Thomas L. Mindt (3 shared papers)Harriet Struthers (3 shared papers)Elisa Garcı́a Garayoa (4 shared papers)Peter Bläuenstein (5 shared papers)
- Journals
- Bioconjugate Chemistry (3 papers)ChemMedChem (3 papers)EJNMMI Research (1 paper)Advances in experimental medicine and biology (1 paper)Nuclear Medicine and Biology (1 paper)
- Partner nations
- BelgiumSwitzerlandGermany
In The Last Decade
Luc Brans
12 papers receiving 657 citations
Peers
Comparison fields: 5 of 56
- Radiology, Nuclear Medicine and Imaging 346
- Oncology 248
- Organic Chemistry 282
- Cellular and Molecular Neuroscience 58
- Molecular Biology 206
Countries citing papers authored by Luc Brans
This map shows the geographic impact of Luc Brans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Brans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Brans more than expected).
Fields of papers citing papers by Luc Brans
This network shows the impact of papers produced by Luc Brans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Brans. The network helps show where Luc Brans may publish in the future.
Co-authors
The 24 scholars most cited alongside Luc Brans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 288 | |
| 2 | 2008 | 82 | |
| 3 | 2008 | 63 | |
| 4 | 2009 | 53 | |
| 5 | 2011 | 50 | |
| 6 | 2011 | 37 | |
| 7 | 2010 | 30 | |
| 8 | 2012 | 16 | |
| 9 | 2010 | 16 | |
| 10 | 2009 | 15 | |
| 11 | 2008 | 14 | |
| 12 | 2009 | 1 |
About Luc Brans
Luc Brans is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Organic Chemistry and Epidemiology, having authored 12 papers that have together received 665 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Peptidase Inhibition and Analysis (7 papers), Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (346 citations), Oncology (248 citations), Organic Chemistry (282 citations), Cellular and Molecular Neuroscience (58 citations) and Molecular Biology (206 citations). Luc Brans has collaborated with scholars based in Belgium, Switzerland and Germany. Frequent co-authors include Dirk Tourwé, Roger Schibli, Véronique Maes, Christian Schweinsberg, Thomas L. Mindt, Harriet Struthers, Elisa Garcı́a Garayoa, Peter Bläuenstein, P. August Schubiger and Elisa García‐Garayoa. Their work appears in journals such as Bioconjugate Chemistry, ChemMedChem, EJNMMI Research, Advances in experimental medicine and biology and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.